Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells.
Saved in:
| Title: | Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells. |
|---|---|
| Authors: | Saleh HA; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Mitwasi N; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Ullrich M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Kubeil M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Toussaint M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Deuther-Conrad W; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Neuber C; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Arndt C; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; Faculty of Medicine Carl Gustav Carus, Mildred Scheel Early Career Center, Technische Universität Dresden, Dresden, Germany., R Loureiro L; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Kegler A; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., González Soto KE; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Belter B; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany., Rössig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Pietzsch J; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden, Germany., Frenz M; Faculty Informatik and Wirtschaftsinformatik, Provadis School of International Management and Technology AG, Frankfurt, Germany., Bachmann M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; National Center for Tumor Diseases Dresden (NCT/UCC), German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site, Dresden, Germany., Feldmann A; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; National Center for Tumor Diseases Dresden (NCT/UCC), German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site, Dresden, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Apr 14; Vol. 14, pp. 1166169. Date of Electronic Publication: 2023 Apr 14 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37122703 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Saleh+HA%22">Saleh HA</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Mitwasi+N%22">Mitwasi N</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Ullrich+M%22">Ullrich M</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Kubeil+M%22">Kubeil M</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Toussaint+M%22">Toussaint M</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Deuther-Conrad+W%22">Deuther-Conrad W</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Neuber+C%22">Neuber C</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Arndt+C%22">Arndt C</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; Faculty of Medicine Carl Gustav Carus, Mildred Scheel Early Career Center, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22R+Loureiro+L%22">R Loureiro L</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Kegler+A%22">Kegler A</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22González+Soto+KE%22">González Soto KE</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Belter+B%22">Belter B</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Rössig+C%22">Rössig C</searchLink>; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Pietzsch+J%22">Pietzsch J</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Frenz+M%22">Frenz M</searchLink>; Faculty Informatik and Wirtschaftsinformatik, Provadis School of International Management and Technology AG, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Bachmann+M%22">Bachmann M</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; National Center for Tumor Diseases Dresden (NCT/UCC), German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Feldmann+A%22">Feldmann A</searchLink>; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; National Center for Tumor Diseases Dresden (NCT/UCC), German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site, Dresden, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Apr 14; Vol. 14, pp. 1166169. <i>Date of Electronic Publication: </i>2023 Apr 14 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37122703 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2023.1166169 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1166169 Titles: – TitleFull: Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Saleh HA – PersonEntity: Name: NameFull: Mitwasi N – PersonEntity: Name: NameFull: Ullrich M – PersonEntity: Name: NameFull: Kubeil M – PersonEntity: Name: NameFull: Toussaint M – PersonEntity: Name: NameFull: Deuther-Conrad W – PersonEntity: Name: NameFull: Neuber C – PersonEntity: Name: NameFull: Arndt C – PersonEntity: Name: NameFull: R Loureiro L – PersonEntity: Name: NameFull: Kegler A – PersonEntity: Name: NameFull: González Soto KE – PersonEntity: Name: NameFull: Belter B – PersonEntity: Name: NameFull: Rössig C – PersonEntity: Name: NameFull: Pietzsch J – PersonEntity: Name: NameFull: Frenz M – PersonEntity: Name: NameFull: Bachmann M – PersonEntity: Name: NameFull: Feldmann A IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 04 Text: 2023 Apr 14 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |